“Thrombectomy” is frequently treated as a single, monolithic category, leading to the misconception that there are too many devices and not enough room to stand out. In practice, thrombectomy spans distinct sub-markets defined by anatomy, indication, access size, and clinical workflow.
Key segments include:
- Acute ischemic stroke (Neurovascular)
- Pulmonary embolism (PE)
- Peripheral arterial disease (PAD)
- Deep vein thrombosis (DVT)
- Dialysis access thrombosis
Each segment has different access requirements, vessel sizes, unique navigational issues, different morphology and hemodynamics,, physician users, device design constraints, and reimbursement dynamics, meaning a tool that excels in one segment is not interchangeable with another.
When thrombectomy is classified properly, segments are highly consolidated at the top rather than broadly overcrowded. In many indications, one or two companies dominate real-world adoption while others play narrower or niche roles.
Across thrombectomy sub-markets, there is a critical distinction between:
- Top-tier dominance across segments
- Second-tier differentiation to the segment leaders
This pattern reflects specific market segment dominance, not saturation or dominance across all thrombectomy segments, and shows that many segments still lack diverse workflow options, access profiles, or anatomy-specific designs.
The segmentation story is especially relevant in peripheral arterial and peripheral venous disease, which are the core focus areas for ICHOR Vascular.
The challenge with lower extremity disease is less about breaking into an overcrowded field and more about offering differentiated, anatomy- and workflow-specific solutions where current therapies have too many tradeoffs. There is substantial room for innovation in thrombectomy, and underscores why ICHOR Vascular is investing in these under-served, high-impact segments with simplicity without compromises.
Read the whitepaper on Why Thrombectomy is Often Misunderstood as a Crowded Market
For more information on what this focused market analysis can mean for your company, email us here and an iCHOR team member will get in touch: